Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NENS”

17 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 17 of 17 results

Early research (Phase 1)Looking for participantsNCT06732505
What this trial is testing

A Phase I Study to Assess the Safety and Efficacy of [225Ac]Ac-DOTATATE in Patients With SSTR+ GEP-Nens

Who this might be right for
Neuroendocrine Neoplasm
Peking University Cancer Hospital & Institute 36
Not applicableUnknownNCT04070131
What this trial is testing

Horse Assisted Rehabilitation Postoncologic Treatment in Children and Adolescents: Physical and Psychological Effects

Who this might be right for
CancerChild, OnlyChild Behavior+2 more
Escoles Universitaries Gimbernat 30
Large-scale testing (Phase 3)Study completedNCT06240741
What this trial is testing

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Who this might be right for
Neuroendocrine Neoplasms
Novartis Pharmaceuticals 71
Testing effectiveness (Phase 2)Looking for participantsNCT07129252
What this trial is testing

Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors

Who this might be right for
SST2-positive Neuroendocrine NeoplasmsNeuroendocrine TumorsNeuroendocrine Neoplasm
Crinetics Pharmaceuticals Inc. 150
Testing effectiveness (Phase 2)Looking for participantsNCT04893785
What this trial is testing

A Trial Evaluating the Activity and Safety of Combination Between Cabozantinib and Temozolomide in Lung and GEP-NENS Progressive After Everolimus, Sunitinib or PRRT (CABOTEM)

Who this might be right for
Lung Neuroendocrine NeoplasmGEP Neuroendocrine Tumor
National Cancer Institute, Naples 35
Not applicableUnknownNCT02523521
What this trial is testing

Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia

Who this might be right for
Bronchopulmonary DysplasiaHealthy
Hospital de Nens de Barcelona 52
Testing effectiveness (Phase 2)Study completedNCT03980925
What this trial is testing

Platinum-doublet Chemotherapy and Nivolumab for the Treatment of Subjects With Neuroendocrine Neoplasms (NENs) of the Gastroenteropancreatic (GEP) Tract or of Unknown (UK) Origin.

Who this might be right for
Neuroendocrine TumorsNeuroendocrine NeoplasmGastroenteropancreatic Neuroendocrine Tumor
Grupo Espanol de Tumores Neuroendocrinos 37
Not applicableStudy completedNCT06983106
What this trial is testing

Correlation Between Body Composition and Pathologic Grade/Prognosis in GEP-NENs: A Retrospective Study

Who this might be right for
Neuroendocrine Tumors
Tongji Hospital 633
Not applicableEnded earlyNCT04488263
What this trial is testing

Natural History Study of Children and Adults With Neuroendocrine Neoplasms (NEN)s

Who this might be right for
Neuroendocrine TumorsCarcinoma, Neuroendocrine
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Looking for participantsNCT07077551
What this trial is testing

NALIRIFOX as Second-Line Chemotherapy in Extrapulmonary High-grade Neuroendocrine Neoplasms: a Prospective, Single-center, Single-arm Trial

Who this might be right for
NENS
Second Affiliated Hospital, School of Medicine, Zhejiang University 28
Testing effectiveness (Phase 2)Looking for participantsNCT05554003
What this trial is testing

Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study

Who this might be right for
Neuroendocrine TumorsFrailtyChemotherapy Effect
European Institute of Oncology 46
Large-scale testing (Phase 3)Looking for participantsNCT07185672
What this trial is testing

PRRT Versus PRRT Plus Chemotherapy in GEP NET (PReCedeNT Trial)

Who this might be right for
Neuroendocrine Neoplasia's (NENs)Neuroendocrine Tumor GEP Grade 1-3Neuroendocrine Gastroenteropancreatic Tumour
Tata Memorial Hospital 162
Testing effectiveness (Phase 2)Study completedNCT04129255
What this trial is testing

Octreotide LAR in the Induction of Immunologic Response in NENs Patients

Who this might be right for
Neuroendocrine Tumors
National Cancer Institute, Naples 34
Not applicableLooking for participantsNCT05237934
What this trial is testing

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Who this might be right for
Neuroendocrine TumorsCarcinoma, Neuroendocrine
National Cancer Institute (NCI) 300
Very early researchUnknownNCT05359146
What this trial is testing

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)

Who this might be right for
Neuroendocrine Neoplasia's (NENs)Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
University Hospital, Basel, Switzerland 16
Not applicableLooking for participantsNCT06356467
What this trial is testing

Influence of Tumour and Patient's Related Factors on the Response to Medical Treatments in Well Differentiated GEP-NENs

Who this might be right for
Neuroendocrine TumorsGEP-NET
IRCCS San Raffaele 450
Testing effectiveness (Phase 2)Looking for participantsNCT06926634
What this trial is testing

Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (HG-NENs)

Who this might be right for
High Grade Neuroendocrine Neoplasms
Washington University School of Medicine 32